August 17, 2026
New handheld spectrophotometer will be showcased with digital color workflow solutions at LOUPE Americas and PRINTING United Expo. GRAND RAPIDS, Mich. -- X-Rite Pantone, the global authority in color standards and color science, announces eXact™ 2 Basic, the newest addition to the eXact 2 family of portable spectrophotometers. Available now, the new device will be showcased [...]
August 13, 2026
Introducing a new AI approach for accelerated biomarker discovery, demonstrated through Alzheimer’s disease biomarker modeling validated in an independent cohort Basel, Switzerland -- Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a new AI agent in Genedata Profiler®, its enterprise platform for integrating and analyzing data across [...]
ZEISS Spectroscopy supports cement industry in reducing fossil fuel use
August 13, 2026
ZEISS Spectroscopy has launched ZEISS SPARC (Spectroscopic Process Analysis & RDF/SRF Control), an innovative inline solution for quality control of alternative fuels in the cement industry. The system will be presented at the Global CemFuels Conference 2026 in Geneva on September 23 and 24, 2026. Jena, Germany | ZEISS Group ZEISS SPARC continuously determines the [...]
August 13, 2026
Newly-created Chief Technology Officer role marks a new chapter for bit.bio as the company expands its leadership team and technology portfolio The ioScreen platform enables pharmaceutical, biotechnology and in silico companies to access industrial-scale CRISPR screening in human stem cell-derived models without building specialist in-house capabilities Service gives researchers a more physiologically relevant way to [...]
SynGenSys introduces expanded CHO.SET synthetic promoter library for enhanced biomanufacturing
August 13, 2026
CHO.SET® 2.0 library of synthetic promoters provide tuneable expression of transgenes whilst maximising CHO cell productivity CHO.SET® promoters enable higher protein titres, reduced costs and shorter development timelines Sheffield, UK: SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the introduction of [...]
Xylem Appoints D. Christian Koch to Board of Directors
August 13, 2026
Xylem (NYSE: XYL), a global water technology leader, today announced that D. Christian Koch has been appointed to the Company’s Board of Directors. Mr. Koch brings more than 30 years of global leadership experience spanning operations, manufacturing, strategy and business transformation. He currently serves as Board Chair, President and Chief Executive Officer of Carlisle Companies [...]
August 12, 2026
Grant funding delivered in partnership with the NC3Rs, in support of UK Government roadmap to reduce animal testing by 2030 Project to develop standardized workflow to more accurately predict drug behaviors, reduce animal testing and streamline development of safer, more effective medicine Delivered in partnership with the National Centre for the Replacement, Refinement and Reduction [...]
Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg
August 12, 2026
WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides antimicrobial susceptibility [...]
Chrysalis and VERDOT Announce Strategic Partnership
August 11, 2026
Chrysalis and VERDOT Announce Strategic Partnership to Expand Access to Advanced Purification Technologies for Emerging Biotech Companies BURLINGTON, MA and SAINT BEAUZIRE, France — Chrysalis Services, LLC and VERDOT today announced a strategic partnership designed to provide biotechnology and biopharma companies with streamlined access to advanced purification technologies within Chrysalis’ GMP ready infrastructure. Through the [...]
August 11, 2026
Olink™ Explore HT analysis of approximately 5,500 research samples completed, with data now available Key Facts Collaboration: Thermo Fisher Scientific and The Michael J. Fox Foundation expanded the Parkinson’s Precision Medicine Initiative (PPMI) proteomic data resource. Scale: Approximately 5,500 research samples were analyzed using Olink technology. Access: The resulting data are available to researchers in PPMI’s repository. Purpose: The [...]

